DelveInsight’s “Diabetic foot ulcers Market Insights, Epidemiology, and Market Forecast -2030“ report delivers an in-depth understanding of the Diabetic foot ulcers, historical and forecasted epidemiology as well as the Diabetic foot ulcers market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Some Facts of the Diabetic foot ulcers Market:
- Increase in Diabetic foot ulcers market size is anticipated for the study period, 2018–2030 with a CAGR of 17.0%.
- As per the DelveInsight estimates, in the 7MM, the total treated cases of DFU were 1,973,895 in the year 2020. These cases are expected to grow with a significant CAGR in the study period 2018–2030.
- In the United States, the total number of prevalent cases of DFU was 4,551,498 cases in the year 2020 which are expected to grow during the study period, i.e., 2018–2030.
- In the year 2020, the total prevalent cases of DFU were 1,274,933 cases in EU-5 which are expected to grow during the study period, i.e., 2018–2030.
- As per the DelveInsight estimates, in the United Kingdom, the total gender-specific prevalent cases of DFU were 66,448 cases for males and 35,780 cases for females in the year 2020.
View Report: https://www.delveinsight.com/report-store/diabetic-foot-ulcers-dfus-market
Request for free Sample Report: https://www.delveinsight.com/sample-request/diabetic-foot-ulcers-dfus-market
Scope of the Diabetic foot ulcers Report:
- The report covers the descriptive overview of Diabetic foot ulcers, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
- Comprehensive insight has been provided into the Diabetic foot ulcers epidemiology and treatment in the 7MM
- Additionally, an all-inclusive account of both the current and emerging therapies for Diabetic foot ulcers are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
- A detailed review of Diabetic foot ulcers market; historical and forecasted is included in the report, covering drug outreach in the 7MM
- The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Diabetic foot ulcers market
“Over 55 million Europeans suffer from diabetes, and 8 million of these patients are at risk of developing a diabetic foot ulcer.”
Diabetic foot ulcers is a lesion of all layers of skin, necrosis, or gangrene that occurs in the sole of the feet in diabetes mellitus (DM) patients, caused by: (1) causative factor (peripheral neuropathy, high foot plantar pressure, and trauma); (2) contributive factors (atherosclerosis and diabetes). Diabetic foot ulcers can be followed by bacterial invasion resulting in infection and decay, can occur in any part of the body especially in the distal part of the lower leg. The sign and symptoms of Diabetic foot ulcers (DFU) includes, swelling, discoloration, and warmth around the wound, foul-smelling discharge seeping from the wound, Pain and firmness when the wound is touched and Call used or thickened skin surrounding the ulcer.
According to Edmon, the diabetic foot ulcers are divided into two groups, namely: Neuropathic ulcers (feet is warm, perfusion is still good with pulsation still palpable, perspiration is reduced, skin dry and cracked).
Neuroischemic ulcers (feet is colder, not palpable pulsation, thin skin, smooth, and without hair, subcutaneous tissue atrophy, intermittent claudication, and rest pain may not be present due to neuropathy).
View Report: https://www.delveinsight.com/report-store/diabetic-foot-ulcers-dfus-market
Request for free Sample Report: https://www.delveinsight.com/sample-request/diabetic-foot-ulcers-dfus-market
Some of the Diabetic foot ulcers Companies:
- Amniox/TissueTech
- HelixMith
- Oneness Biotech
- Rheacell
- Lakewood-Amedex
- Regen Lab
- And many others
Diabetic foot ulcers Drugs Covered:
- TTAX01
- Engensis
- ON101
- Allo-APZ2-DFU
- Bisphosphocin Nu-3
- Autologous platelet rich plasma gel
- And many others
View Report: https://www.delveinsight.com/report-store/diabetic-foot-ulcers-dfus-market
Request for free Sample Report: https://www.delveinsight.com/sample-request/diabetic-foot-ulcers-dfus-market
Table of Contents:
- Report Introduction
- Diabetic Foot Ulcers Market Overview at a Glance
- Diabetic Foot Ulcers Disease Background and Overview
- Diabetic Foot Ulcers Epidemiology and Patient Population
- Diabetic Foot Ulcers Country- Wise Epidemiology
5.1. United States
5.2. EU-5
5.2.1. Germany
5.2.2. France
5.2.3. Italy
5.2.4. Spain
5.2.5. United Kingdom
5.3. Japan
- Diabetic Foot Ulcers Treatment & Medical Practices
- Diabetic Foot Ulcers Marketed Drugs
7.1. Regranex Gel (becaplermin): Smith & Nephew
- Diabetic Foot Ulcers Emerging Therapies
8.1. Key Cross Competition
8.2. Plasma-generated nitric oxide: Originww
8.3. MBN-101: Microbion Corporation
- Diabetic Foot Ulcers Market Size
- 7MM Diabetic Foot Ulcers Country-Wise Market Analysis
10.1. United States
10.2. Germany
10.3. France
10.4. Italy
10.5. Spain
10.6. United Kingdom
10.7. Japan
- Diabetic Foot Ulcers Report Methodology
- DelveInsight Capabilities
- Disclaimer
- About DelveInsight
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognised for its off-the-shelf syndicated market research reports as well as customised solutions to firms in the healthcare sector.